和黄医药(00013)启动HMPL-760用于治疗复发/难治性弥漫性大B细胞淋巴瘤的中国III期临床试验
Last Update:
23 3 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.